Stemming from the 2012/2013 BioInnovate Program, ProVerum Medical was established by Dr Conor Harkin to develop a novel, minimally invasive treatment for patients with symptomatic Benign Prostatic Hyperplasia (BPH), an enlargement of the prostate gland, causing difficulty with urination. In April 2018, ProVerum Medical announced that it had closed a $4.2 million seed investment with Atlantic Bridge University Fund leading the investment round, a round which also included HBAN Medtech Syndicate, Irrus Investments, Boole and Xenium Capital. The team continues its journey to develop the product in preparation for full commercialisation.


Our Location

Situated on the prestigious campus of National University of Ireland Galway within the medieval city of Galway, European Capital of Culture in 2020, with equal easy access to the wilderness of Connemara in the west and the European mainland in the east, BioInnovate boasts a superb location.

Our affiliation with Stanford BioDesign has helped us to become one of the world’s leading innovation hubs with an immense debt of gratitude owed to Enterprise Ireland for both their financial and professional support in helping BioInnovate grow.

Contact Us Today
BioInnovate Ireland Block E
National University of Ireland Galway,
Ireland +353 (0)91 492 646